The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1997-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM.82.9.4192PMID 9284746
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is leptin the link between obesity and insulin resistance?

  1997cited by this paper
• Sexual dimorphism in plasma leptin concentration.

  1997cited by this paper
• Leptin concentrations, sex hormones, and cortisol in nondiabetic men.

  1997cited by this paper
• Leptin is a metabolic signal to the reproductive system.

  1996cited by this paper
• Radioimmunoassay of leptin in human plasma.

  1996cited by this paper
• Gender differences in plasma leptin concentrations

  1996cited by this paper
• Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome.

  1996cited by this paper
• Relationship Between Insulin Sensitivity and Plasma Leptin Concentration in Lean and Obese Men

  1996cited by this paper
• Effect of Puberty on Markers of Glomerular Hypertrophy and Hypertension in IDDM

  1996cited by this paper
• Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue

  1996cited by this paper
• Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin

  1996cited by this paper
• Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

  1996cited by this paper
• Novel B219/OB receptor isoforms: Possible role of leptin in hematopoiesis and reproduction

  1996cited by this paper
• Effects of gender, body composition, and menopause on plasma concentrations of leptin.

  1996cited by this paper
• Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates.

  1996cited by this paper
• The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women.

  1996cited by this paper
• Positional cloning of the mouse obese gene and its human homologue

  1995cited by this paper
• Metabolic regulation of androgen production by human thecal cells in vitro.

  1995cited by this paper
• Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus.

  1995cited by this paper
• Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats.

  1995cited by this paper
• Increased obese mRNA expression in omental fat cells from massively obese humans

  1995cited by this paper
• Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects

  1995cited by this paper
• The role of dual energy X-ray absorptiometry of lumbar spine and proximal femur in the diagnosis and follow-up of osteoporosis.

  1995cited by this paper
• Overexpression of the obese (ob) gene in adipose tissue of human obese subjects

  1995cited by this paper
• Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factors.

  1994cited by this paper
• Positional cloning of the mouse obese gene and its human homologue

  1994cited by this paper
• The effect of a biphasic desogestrel-containing oral contraceptive on carbohydrate metabolism and various hormonal parameters.

  1993cited by this paper
• How good a marker is insulin level for insulin resistance?

  1993cited by this paper
• Insulin resistance, secretion, and metabolism in users of oral contraceptives.

  1992cited by this paper
• Polycystic ovary syndrome and the androgen-insulin connection.

  1991cited by this paper
• Acanthosis Nigricans, insulin action, and hyperandrogenism: clinical, histological, and biochemical findings.

  1991cited by this paper
• Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease.

  1990cited by this paper
• The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.

  1990cited by this paper
• Two sexually dimorphic cell groups in the human brain

  1989cited by this paper
• New progestogens in oral contraceptives

  1988cited by this paper
• The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism.

  1988cited by this paper
• Report of Study Group I

  1973cited by this paper

• Combined oral contraceptives: Why, when, where?

  2022cites this paper
• EFFECT OF CHLORMADINONE-CONTAINING CONTRACEPTIVES ON CARBOHYDRATE AND LIPID METABOLISM IN WOMEN WITH METABOLIC SYNDROME

  2021cites this paper
• Androgens and Cardiovascular Risk Factors in Polycystic Ovary Syndrome

  2021cites this paper
• Polycystic ovary syndrome (PCOS) and adolescence: How can we manage it?

  2020cites this paper
• The effects of physical exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: a systematic review and meta-analysis

  2019cites this paper
• Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational study

  2019cites this paper
• Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis

  2018cites this paper
• Comparing the Effects of Combined Oral Contraceptives Containing Progestins With Low Androgenic and Antiandrogenic Activities on the Hypothalamic-Pituitary-Gonadal Axis in Patients With Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis

  2018cites this paper
• Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens.

  2017cites this paper
• Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome

  2017influential citation
• Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome

  2017cites this paper
• Inositol(s) from Bench to Bedside in Endocrinology and Gynecology

  2017cites this paper
• Myo-Inositol in the Treatment of Teenagers Affected by PCOS

  2016cites this paper
• Menstrual cyclicity post OC withdrawal in PCOS: Use of non-hormonal options

  2016cites this paper
• A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome.

  2016cites this paper
• Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome

  2016influential citation
• Approach to the patient: contraception in women with polycystic ovary syndrome.

  2015cites this paper
• Physiological and Hormonal Factors that Influence Leptin Production

  2015cites this paper
• Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome.

  2015cites this paper
• How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology

  2015cites this paper
• Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome

  2014cites this paper
• Effect of a high-fructose diet on glucose tolerance, plasma lipid and hemorheological parameters during oral contraceptive administration in female rats

  2013cites this paper
• Oral contraceptives and cardiovascular risk in women with polycystic ovary syndrome

  2013cites this paper
• Contraception for Women With PCOS: Benefit Versus Risk

  2013cites this paper
• Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.

  2012cites this paper
• Combined estrogen-progestogen but not progestogen-only oral contraceptive alters glucose tolerance and plasma lipid profile in female rats.

  2012cites this paper
• The effects of old, new and emerging medicines on metabolic aberrations in PCOS

  2012cites this paper
• Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment

  2011cites this paper
• The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies.

  2011cites this paper
• [The influence of low-dose oral contraceptive pill on clinical and metabolic parameters in young women with polycystic ovary syndrome].

  2011cites this paper
• Current procedures for managing polycystic ovary syndrome

  2010cites this paper
• Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study.

  2010cites this paper
• Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome.

  2010cites this paper
• GDAŃSKI UNIWERSYTET MEDYCZNY

  2009cites this paper
• The Effects of Rosiglitazone, Metformin, and Estradiol-cyproterone Acetate on Lean Patients With Polycystic Ovary Syndrome

  2009cites this paper
• Polycystic Ovary Syndrome

  2009cites this paper
• Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome

  2009cites this paper
• Oral Contraceptives in Polycystic Ovary Syndrome: Risk-Benefit Assessment

  2008cites this paper
• [Obesity and reproduction: a literature review].

  2008cites this paper
• Metformin treatment does not affect total leptin levels and free leptin index in obese patients with polycystic ovary syndrome.

  2008cites this paper
• Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome

  2008cites this paper
• Treatment of hirsutism with combined pill containing drospirenone

  2008cites this paper
• The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: An updated systematic review

  2008cites this paper
• Treatment for polycystic ovary syndrome: a critical appraisal of treatment options

  2008cites this paper
• Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications

  2008cites this paper
• Pharmaceutical Intervention in Metabolic and Cardiovascular risk Factors in Polycystic Ovary Syndrome

  2007cites this paper
• Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis.

  2007cites this paper
• Pharmacologic Therapy of Polycystic Ovary Syndrome

  2007cites this paper
• Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism

  2007cites this paper
• Polycystic Ovarian Syndrome: An Evidence-based Approach to Evaluation and Management of Diabetes and Cardiovascular Risks for Today's Clinician

  2007cites this paper
• Diet and Lifestyle Factors in the Etiology and Management of Polycystic Ovary Syndrome

  2007cites this paper
• Polycystic Ovary Syndrome: Lifestyle factors in the etiology and management of polycystic ovary syndrome

  2007cites this paper
• Use of oral contraceptives in the treatment of women with polycystic ovary syndrome

  2007cites this paper
• Chronic Treatment of Polycystic Ovary Syndrome

  2007cites this paper
• Tratamiento del síndrome de ovario poliquístico: Anticonceptivos orales

  2007cites this paper
• Effects of Medical Therapy on Insulin Resistance and the Cardiovascular System in Polycystic Ovary Syndrome

  2007cites this paper
• Transgender Primary Medical Care

  2006cites this paper
• Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome.

  2006cites this paper
• Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens.

  2006cites this paper
• Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS

  2006cites this paper
• Effects of insulin-lowering drugs in PCOS: endocrine, metabolic and inflammatory aspects

  2006cites this paper
• Update on Polycystic Ovary Syndrome

  2006cites this paper
• Comparing rosiglitazone with ethinylestradiol/cyproterone acetate in the treatment of polycystic ovary syndrome

  2006cites this paper
• Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome.

  2005cites this paper
• Combined oral contraceptives in the treatment of polycystic ovary syndrome.

  2005influential citation
• Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome.

  2005cites this paper
• Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study.

  2005cites this paper
• Randomized Controlled Trial Evaluating Response to Metformin Versus Standard Therapy in the Treatment of Adolescents with Polycystic Ovary Syndrome

  2005cites this paper
• Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome.

  2004cites this paper
• Hirsutism and acne in polycystic ovary syndrome.

  2004cites this paper
• der Plasmakonzentration von Diabetikern und Stoffwechselgesunden im Hinblick auf diabetogene Hormone unter besonderer Berücksichtigung von Resistin

  2004cites this paper
• Letrozole induction of ovulation in clomiphene citrate resistantpolycystic ovary syndrome: responders and non-responders

  2004cites this paper
• Definitions of the insulin resistance syndrome: the 1st World Congress on the Insulin Resistance Syndrome.

  2004cites this paper
• The 1st World Congress on the Insulin Resistance Syndrome.

  2004cites this paper
• Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome.

  2003cites this paper
• CONTROVERSIES IN ENDOCRINOLOGY : A MODERN MEDICAL QUANDARY: POLYCYSTIC OVARY SYNDROME, INSULIN RESISTANCE AND ORAL CONTRACEPTIVE PILLS

  2003cites this paper
• American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25-26 August 2002, Washington, DC.

  2003cites this paper
• Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel.

  2003cites this paper
• The role of leptin in fertility.

  2003cites this paper
• Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.

  2003cites this paper
• American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25-26 August 2002, Washington, DC.

  2003cites this paper
• Insulin Sensitizers for Polycystic Ovary Syndrome

  2003cites this paper
• A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills.

  2003cites this paper
• Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study.

  2002cites this paper
• Finally, it is our turn!

  2002cites this paper
• Relationship between body composition, sex hormones and leptinemia in hemodialyzed patients with chronic renal failure.

  2002cites this paper
• Effects of oral contraceptives with low-dose estrogen and desogestrel on leptin concentrations.

  2002cites this paper
• Leptin, nutrition and reproduction: new insights.

  2002cites this paper
• Should patients with polycystic ovarian syndrome be treated with metformin?: an enthusiastic endorsement.

  2002cites this paper
• Loss of gender difference in serum leptin levels and its slow recovery after successful surgery for Leydig cell tumours in two virilized females

  2001cites this paper
• Nuevas indicaciones de los agentes sensibilizantes a la insulina: hiperinsulinismo e hiperandrogenismo en la adolescencia y síndrome del ovario poliquístico

  2001cites this paper
• Role of diabetes in influencing leptin concentration in elderly overweight patients.

  2001cites this paper
• Clinical management of PCOS

  2001cites this paper
• The influence of long-term administration of conjugated estrogens and antiandrogens to serum leptin levels in women with polycystic ovary syndrome

  2000cites this paper
• Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.

  2000cites this paper
• Basal leptin concentrations in women with normal and dysfunctional ovarian conditions

  2000cites this paper
• Acute inhibition of oestrogen biosynthesis does not affect serum leptin levels in young men.

  2000cites this paper
• Insulin resistance in polycystic ovary syndrome

  2000cites this paper
• Effects of administration of 17β‐oestradiol on serum leptin levels in healthy postmenopausal women

  1999cites this paper
• Serum leptin concentrations in women taking oral contraceptives.

  1999cites this paper